The differences in AKR1C3 immunoreactivity obtained from sections prepared from an individual patient and tissue arrays might result from the uneven distribution of AKR1C3 in prostate adenocarcinoma. The gene discussed is AKR1C3; the disease is prostate adenocarcinoma.